JD Health, KYG8208B1014

JD stock holds after a 2026 profit swing

Published on 08/29/2026 at 17:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JD stock is backed by a 1.3% operating margin and $38.64 billion market value as investors weigh the latest 2026 results.

JD Health, KYG8208B1014, Illustration mit AI erstellt.
JD Health, KYG8208B1014, Illustration mit AI erstellt.

JD.com (KYG8208B1014) is trading against a backdrop of a $38.64 billion market value and a 1.3% operating margin in the second quarter ended June 30, 2026. The latest report also showed revenue of RMB 346.4 billion, down 2.9% year over year, while diluted EPS rose 20.7% to RMB 5.01.

That mix matters because the quarter turned operating profit back to RMB 4.5 billion from a loss a year earlier, while non-GAAP operating income reached RMB 5.5 billion. Revenue declined, but the profit rebound and EPS growth gave the market a cleaner read on margin discipline.

Profitability is the key read

The second quarter margin improvement from -0.2% a year earlier to 1.3% shows why investors keep focusing on execution rather than headline sales alone. Non-GAAP operating margin reached 1.6%, up from 0.3% in the same period last year, which is a concrete sign that cost control and mix helped the bottom line.

Consumer demand and platform scale still matter, but the comparison now leans more heavily toward efficiency. Revenue of RMB 346.4 billion was lower than the prior-year quarter, yet the company still delivered stronger profitability metrics across operating income and EPS.

What the market is pricing

A separate market snapshot put JD.com at $28.64 per share as of August 28, 2026, with a market capitalization of $38.67 billion. That leaves the stock close to the value band implied by recent market commentary, where a quoted GF Value stood at $38.24.

The comparison is simple: a stock at $28.64 against a $38.24 reference implies a wide valuation gap, even after the stronger second-quarter profit profile. For investors, the next debate is whether earnings quality continues to improve fast enough to close that spread.

JD Health links the group

JD Health is also part of the wider JD ecosystem through the Hang Seng Tech reshuffle, with removal effective September 14, 2026 and a related notice published on August 29, 2026. That keeps the broader JD complex in view for investors who follow the family of listed assets as a single valuation story.

Consumer platform core

JD.com remains a retail and logistics platform built around direct commerce, marketplace services, and supply-chain infrastructure. The second-quarter numbers show how that model can still produce operating leverage when margins improve faster than revenue grows.

Stock view and trading level

The shares were last quoted at $28.64 on August 28, 2026, with a market capitalization of $38.67 billion. The market is still testing how much of the 2026 profit recovery deserves a higher multiple.

More on JD stock

More on JD stock

Fact box

Company: JD.com, Inc.

ISIN: KYG8208B1014

Ticker: JD

Exchange: Nasdaq

Price (as of August 28, 2026, 4:00 p.m. ET): $28.64 USD

Market cap: $38.67 billion (as of August 28, 2026)

Sector / Industry: Consumer Discretionary / Broadline Retail

Index membership: Nasdaq-100

Next earnings date: November 2026

About JD stock

JD stock is tied to a business that delivered RMB 346.4 billion in revenue and RMB 5.01 diluted EPS in the second quarter ended June 30, 2026.

Disclaimer...

en | KYG8208B1014 | JD HEALTH | boerse | 70021149 | bgmi